HOOKIPA Pharma Inc. (HOOK)
USD 2.0
(-6.1%)
USD 2.0
(-6.1%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -57.52 Million | -19.99 Million | -66.01 Million | -39.33 Million | -41.73 Million | -14.99 Million |
| Net Income | -81.58 Million | -64.91 Million | -75.66 Million | -44.08 Million | -43.03 Million | -16.23 Million |
| Depreciation & Amortization | 3.55 Million | 3.6 Million | 4.64 Million | 4.15 Million | 1.44 Million | 640 Thousand |
| Deferred income taxes | -12.67 Million | - | - | - | - | - |
| Stock-based compensation | 2.34 Million | 5.04 Million | 7.64 Million | 8.65 Million | 5.56 Million | 867 Thousand |
| Change in working capital | 5.32 Million | 36.11 Million | -3.86 Million | -8.11 Million | -7.37 Million | -275 Thousand |
| Other non-cash items | 25.5 Million | 160 Thousand | 1.22 Million | 53 Thousand | 1.67 Million | 7000.00 |
| Investing Cash Flow | -4.15 Million | -5.01 Million | -12.58 Million | -2.37 Million | -1.99 Million | -2.15 Million |
| Investments in PPE | -4.15 Million | -5.01 Million | -12.58 Million | -2.37 Million | -1.99 Million | -2.15 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 65.67 Million | 72.27 Million | -235 Thousand | 73.42 Million | 109.75 Million | 6.87 Million |
| Debt repayment | -1.75 Million | -2.85 Million | -438 Thousand | -1.41 Million | -2.27 Million | -425 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 67.42 Million | 75.12 Million | 203 Thousand | 42.63 Million | 74.75 Million | 9000.00 |
| Other Financing Activities | -149 Thousand | 75.12 Million | -235 Thousand | 32.2 Million | 37.27 Million | 6.86 Million |
| Accounts receivables | 3.45 Million | -341 Thousand | -1.94 Million | -3.57 Million | -3.61 Million | -4.99 Million |
| Accounts payables | 6.49 Million | -1.99 Million | 858 Thousand | 6.29 Million | 4.2 Million | 3.41 Million |
| Inventory | - | - | -4.19 Million | -11.35 Million | -3.52 Million | -7.28 Million |
| Other working capital | -4.62 Million | 38.45 Million | 1.42 Million | 511 Thousand | -4.44 Million | 8.58 Million |
| Cash at beginning of period | 113.02 Million | 66.91 Million | 143.17 Million | 113.57 Million | 48.58 Million | 61.36 Million |
| Cash at end of period | 117.09 Million | 113.44 Million | 66.91 Million | 143.17 Million | 113.57 Million | 48.58 Million |
| Capital Expenditure | -4.15 Million | -5.01 Million | -12.58 Million | -2.37 Million | -1.99 Million | -2.15 Million |
| Effect of forex changes on cash | 90 Thousand | -725 Thousand | 2.56 Million | -2.1 Million | -1.02 Million | -2.5 Million |
| Net cash flow / Change in cash | 4.07 Million | 46.53 Million | -76.26 Million | 29.6 Million | 64.99 Million | -12.78 Million |
| Free Cash Flow | -61.68 Million | -25.01 Million | -78.59 Million | -41.71 Million | -43.73 Million | -17.14 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -19.09 Million | 14.38 Million | -81.58 Million | -24.81 Million | -19.06 Million | -18.01 Million |
| Depreciation & Amortization | 714 Thousand | 640 Thousand | 3.55 Million | 1.27 Million | 487 Thousand | 866 Thousand |
| Deferred income taxes | - | - | -12.67 Million | 4.26 Million | -5.91 Million | -838 Thousand |
| Stock-based compensation | 459 Thousand | -249 Thousand | 2.34 Million | 417 Thousand | 574 Thousand | 696 Thousand |
| Change in working capital | 3.54 Million | -38.93 Million | 5.32 Million | -927 Thousand | -6.11 Million | -2.87 Million |
| Other non-cash items | -5.75 Million | 13.37 Million | 25.5 Million | 8.56 Million | 5.91 Million | 838 Thousand |
| Investing Cash Flow | -45 Thousand | -116 Thousand | -4.15 Million | -422 Thousand | -3.01 Million | -445 Thousand |
| Investments in PPE | -45 Thousand | -116 Thousand | -4.15 Million | -422 Thousand | -3.01 Million | -445 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -1.14 Million | -135 Thousand | 65.67 Million | 21.24 Million | -659 Thousand | 45.81 Million |
| Debt repayment | -1.14 Million | - | -1.75 Million | -1.75 Million | - | -1.15 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -395 Thousand | - |
| Common Stock Issuance | - | -135 Thousand | 67.42 Million | 21.24 Million | -395 Thousand | 28.18 Million |
| Other Financing Activities | -1.14 Million | -135 Thousand | -149 Thousand | 32.26 Million | -264 Thousand | 18.78 Million |
| Accounts receivables | 8.21 Million | -11.67 Million | 3.45 Million | 4.84 Million | -419 Thousand | 118 Thousand |
| Accounts payables | -580 Thousand | -669 Thousand | 6.49 Million | 2.39 Million | -1.08 Million | 3.63 Million |
| Inventory | - | - | - | 2.86 Million | 1.44 Million | -4.31 Million |
| Other working capital | -4.09 Million | -26.58 Million | -4.62 Million | -8.16 Million | -6.06 Million | -2.31 Million |
| Cash at beginning of period | 92.75 Million | 117.09 Million | 113.02 Million | 107.67 Million | 136 Million | 110.02 Million |
| Cash at end of period | 77.15 Million | 92.75 Million | 117.09 Million | 117.09 Million | 108.09 Million | 136 Million |
| Capital Expenditure | -45 Thousand | -116 Thousand | -4.15 Million | -422 Thousand | -3.01 Million | -445 Thousand |
| Effect of forex changes on cash | -40 Thousand | -159 Thousand | 90 Thousand | -177 Thousand | -118 Thousand | -49 Thousand |
| Net cash flow / Change in cash | -15.6 Million | -24.34 Million | 4.07 Million | 9.42 Million | -27.91 Million | 25.98 Million |
| Free Cash Flow | -14.42 Million | -24.27 Million | -61.68 Million | -11.64 Million | -27.13 Million | -19.77 Million |
COME
FCF
ANGI
688001
IFA1V
SMBZF